DE1115350B
(de)
|
1959-04-17 |
1961-10-19 |
Siemens Ag |
Selbstschalter, insbesondere Leitungsschutz-schalter, mit einem aus einem Kniegelenk bestehenden Antriebsmechanismus fuer das Schaltorgan
|
GB971307A
(en)
|
1961-03-02 |
1964-09-30 |
Wellcome Found |
5-anilinopyrimidines
|
GB1127875A
(en)
|
1967-03-23 |
1968-09-18 |
Parke Davis & Co |
4-(5-nitro-2-furyl) thiazolyl hydantoins and hydrouracils
|
US3949002A
(en)
|
1970-11-13 |
1976-04-06 |
Imperial Chemical Industries Limited |
Process for producing sulfone containing thiophenols
|
US3818024A
(en)
|
1972-02-16 |
1974-06-18 |
Velsicol Chemical Corp |
Benzothiazol substituted thiadiazolidines
|
CH565887A5
(lt)
|
1972-08-22 |
1975-08-29 |
Ciba Geigy Ag |
|
US3939122A
(en)
|
1973-04-11 |
1976-02-17 |
Bayer Aktiengesellschaft |
Process for the preparation of compounds which contain hydantoin rings
|
FR2337554A1
(fr)
|
1976-01-08 |
1977-08-05 |
Buzas Andre |
Nouveaux derives de la pyrazolidinedione
|
JPS5915247B2
(ja)
|
1976-09-14 |
1984-04-09 |
古河電気工業株式会社 |
電力制御による走行体の定位置停止方式
|
US4093624A
(en)
|
1977-01-31 |
1978-06-06 |
Icn Pharmaceuticals, Inc. |
1,2,4-Thiadiazolidine-3,5-dione
|
FR2396549A2
(fr)
|
1977-07-06 |
1979-02-02 |
Buzas Andre |
Nouveaux derives de la pyrazolidinedione
|
US4256758A
(en)
|
1979-06-11 |
1981-03-17 |
Merck & Co., Inc. |
4-Substituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase
|
US4298743A
(en)
|
1979-09-11 |
1981-11-03 |
Merck & Co., Inc. |
4-(Substituted phenyl thiazolyl)-3-hydroxy-3-pyrroline-2,5-diones
|
US4296237A
(en)
|
1979-09-11 |
1981-10-20 |
Merck & Co., Inc. |
4-(Pyridyl, piperazinyl and thiazolyl substituted thiazolyl)-3-hydroxy-3-pyrroline-2,5-diones
|
US4432992A
(en)
|
1979-11-05 |
1984-02-21 |
Merck & Co., Inc. |
4-[5(and 4)-Substituted-2-thienyl]-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase
|
US4366189A
(en)
|
1979-12-21 |
1982-12-28 |
Ciba-Geigy Corporation |
4-Heterocyclyl-4'-vinylstilbenes
|
JPS59177557A
(ja)
|
1983-03-28 |
1984-10-08 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
DE3406329A1
(de)
|
1984-02-22 |
1985-08-22 |
Merck Patent Gmbh, 6100 Darmstadt |
Pyridone
|
US4816454A
(en)
|
1984-09-21 |
1989-03-28 |
Cassella Aktiengesellschaft |
4,5-dihydro-3(2H)-pyridazinones and their pharmacological use
|
US5514691A
(en)
|
1993-05-20 |
1996-05-07 |
Immunopharmaceutics, Inc. |
N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin
|
US5103014A
(en)
|
1987-09-30 |
1992-04-07 |
American Home Products Corporation |
Certain 3,3'-[[[(2-phenyl-4-thiazolyl)methoxy]phenyl]methylene]dithiobis-propanoic acid derivatives
|
AU606808B2
(en)
|
1988-06-29 |
1991-02-14 |
Otsuka Pharmaceutical Factory, Inc. |
Arylcarboxamide substituted by alkylphosphonates, process for preparing the same and a pharmaceutical composition containing the same
|
FR2662162B1
(fr)
|
1990-05-18 |
1995-01-20 |
Adir |
Nouveaux derives de l'amino piperidine, de l'amino pyrrolidine et de l'amino perhydroazepine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
|
GB9012936D0
(en)
|
1990-06-11 |
1990-08-01 |
Fujisawa Pharmaceutical Co |
Thiophene derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
|
US5254715A
(en)
|
1990-11-07 |
1993-10-19 |
Warner-Lambert Company |
Aminosulfonyl carbamates
|
WO1992012966A1
(fr)
|
1991-01-21 |
1992-08-06 |
Shionogi Seiyaku Kabushiki Kaisha |
Analogue de 3-benzylidene-1-carbamoyl-2-pyrrolidone
|
US5162360A
(en)
|
1991-06-24 |
1992-11-10 |
Warner-Lambert Company |
2-heteroatom containing urea and thiourea ACAT inhibitors
|
GB9816837D0
(en)
|
1998-08-04 |
1998-09-30 |
Zeneca Ltd |
Amide derivatives
|
GB9125515D0
(en)
|
1991-11-29 |
1992-01-29 |
Merck Sharp & Dohme |
Therapeutic agents
|
EP0670320A4
(en)
|
1992-12-01 |
1997-05-02 |
Green Cross Corp |
DERIVATIVE OF 1,8-NAPHTHYRIDIN-2-ONE AND USE OF THIS DERIVATIVE.
|
DE4302702A1
(de)
|
1993-02-01 |
1994-08-04 |
Bayer Ag |
Arylaminosulfonylharnstoffe
|
AU6518694A
(en)
|
1993-03-19 |
1994-10-11 |
Dowelanco |
A process for preparing halogenated isothiazoles
|
WO1994022872A1
(en)
|
1993-03-30 |
1994-10-13 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Cell adhesion inhibitor and thienotriazolodiazepine compound
|
WO1994024095A1
(en)
|
1993-04-16 |
1994-10-27 |
Abbott Laboratories |
Immunosuppressive agents
|
CA2123728A1
(en)
|
1993-05-21 |
1994-11-22 |
Noriyoshi Sueda |
Urea derivatives and their use as acat inhibitors
|
WO1995006044A1
(en)
|
1993-08-20 |
1995-03-02 |
Smithkline Beecham Plc |
Amide and urea derivatives as 5ht1d receptor antagonists
|
DE4337847A1
(de)
|
1993-11-05 |
1995-05-11 |
Bayer Ag |
Substituierte Phenylaminosulfonylharnstoffe
|
US5801170A
(en)
|
1993-12-07 |
1998-09-01 |
Smithkline Beecham Plc |
Heterocyclic biphenylylamides useful as 5HT1D antagonists
|
DE4343831A1
(de)
|
1993-12-22 |
1995-06-29 |
Magyar Tudomanyos Akademia |
Substituierte Sulfonylharnstoffe
|
FR2715155B1
(fr)
|
1994-01-19 |
1996-07-26 |
Mayoly Spindler |
Inhibiteurs de la monoamine oxydase B et leurs procédés de préparation.
|
DE4414840A1
(de)
|
1994-04-28 |
1995-11-02 |
Bayer Ag |
Substituierte Phenylaminosulfonylharnstoffe
|
DE69530690T2
(de)
|
1994-06-15 |
2004-03-18 |
Otsuka Pharmaceutical Co., Ltd. |
Benzoheterocyclische derivate verwendbar als vasopressin- oder oxytocin-modulatoren
|
BR9509768A
(pt)
|
1994-11-24 |
1998-07-07 |
Hoffmann La Roche |
Novas pirimidinas de benzila
|
US5494925A
(en)
|
1994-12-02 |
1996-02-27 |
Sterling Winthrop Inc. |
2-heterocyclyloxymethyl and 2-heterocyclylthiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
|
NZ298036A
(en)
|
1994-12-22 |
1998-11-25 |
Smithkline Beecham Plc |
Tetracyclic spiro compounds and medicaments thereof
|
US5990133A
(en)
|
1995-02-02 |
1999-11-23 |
Smithkline Beecham P.L.C. |
Indole derivatives as 5-HT receptor antagonist
|
DE69629413T2
(de)
|
1995-04-24 |
2004-04-01 |
Semiconductor Energy Laboratory Co., Ltd., Atsugi |
Flüssigkristallverbindung und diese enthaltende Flüssigkristall-Zusammensetzung
|
US6123964A
(en)
*
|
1995-10-27 |
2000-09-26 |
Merck & Co., Inc. |
Wet granulation formulation of a growth hormone secretagogue
|
JPH09221476A
(ja)
|
1995-12-15 |
1997-08-26 |
Otsuka Pharmaceut Co Ltd |
医薬組成物
|
GB9605945D0
(en)
|
1996-03-21 |
1996-05-22 |
Smithkline Beecham Plc |
Novel compounds
|
GB9607219D0
(en)
|
1996-04-04 |
1996-06-12 |
Smithkline Beecham Plc |
Novel compounds
|
SK286662B6
(sk)
|
1996-04-23 |
2009-03-05 |
Vertex Pharmaceuticals Incorporated |
Deriváty močoviny, farmaceutické prostriedky, ktoré ich obsahujú, a ich použitie ako inhibítorov aktivity IMPDH enzýmu
|
US6147088A
(en)
|
1996-05-20 |
2000-11-14 |
Merck & Co., Inc. |
Antagonists of gonadotropin releasing hormone
|
WO1997045400A1
(en)
|
1996-05-24 |
1997-12-04 |
Neurosearch A/S |
Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
|
GB9623833D0
(en)
|
1996-11-16 |
1997-01-08 |
Zeneca Ltd |
Chemical compound
|
US6020357A
(en)
|
1996-12-23 |
2000-02-01 |
Dupont Pharmaceuticals Company |
Nitrogen containing heteroaromatics as factor Xa inhibitors
|
ATE230742T1
(de)
|
1997-03-27 |
2003-01-15 |
Great Lakes Chemical Europ |
2-(2'-hydroxphenyl)-benzotriazole und ihre verwendung als lichtschutzmittel für organische polymere
|
DE1019040T1
(de)
|
1997-05-23 |
2001-02-08 |
Bayer Ag |
Hemmung von p38 kinase aktivität durch arylharnstoff
|
US6187799B1
(en)
|
1997-05-23 |
2001-02-13 |
Onyx Pharmaceuticals |
Inhibition of raf kinase activity using aryl ureas
|
US6294573B1
(en)
|
1997-08-06 |
2001-09-25 |
Abbott Laboratories |
Reverse hydroxamate inhibitors of matrix metalloproteinases
|
US6235786B1
(en)
|
1997-08-06 |
2001-05-22 |
Abbott Laboratories |
Reverse hydroxamate inhibitors of matrix metalloproteinases
|
WO1999015164A1
(en)
|
1997-09-23 |
1999-04-01 |
Zeneca Limited |
Amide derivatives for the treatment of diseases mediated by cytokines
|
IT1295933B1
(it)
|
1997-10-30 |
1999-05-28 |
Great Lakes Chemical Italia |
2-(2'-idrossifenil)benzotriazoli e procedimento per la loro preparazione
|
US6080763A
(en)
|
1997-11-03 |
2000-06-27 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds and their use as anti-inflammatory agents
|
US7329670B1
(en)
|
1997-12-22 |
2008-02-12 |
Bayer Pharmaceuticals Corporation |
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
US20080300281A1
(en)
|
1997-12-22 |
2008-12-04 |
Jacques Dumas |
Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
|
PT1056725E
(pt)
|
1997-12-22 |
2006-09-29 |
Bayer Pharmaceuticals Corp |
Inibicao da raf-quinase usando ureias heterociclicas substituidas com arilo e heteroarilo
|
US20070244120A1
(en)
|
2000-08-18 |
2007-10-18 |
Jacques Dumas |
Inhibition of raf kinase using substituted heterocyclic ureas
|
EP1043995B9
(en)
|
1997-12-22 |
2008-10-08 |
Bayer Pharmaceuticals Corp. |
INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
|
CZ299156B6
(cs)
|
1997-12-22 |
2008-05-07 |
Bayer Corporation |
Substituované heterocyklické mocoviny, farmaceutické prípravky je obsahující a jejich použití
|
JP4403482B2
(ja)
|
1997-12-22 |
2010-01-27 |
バイエル コーポレイション |
置換複素環尿素合成のための中間体およびその製造方法
|
NZ333399A
(en)
|
1997-12-24 |
2000-05-26 |
Sankyo Co |
Cyclooxygenase-2 inhibitors (COX-2) for the prevention and treatment of tumors, cachexia and tumor-metastasis
|
EP0928790B1
(en)
|
1998-01-02 |
2003-03-05 |
F. Hoffmann-La Roche Ag |
Thiazole derivatives
|
JPH11209350A
(ja)
|
1998-01-26 |
1999-08-03 |
Eisai Co Ltd |
含窒素複素環誘導体およびその医薬
|
DE69812070T2
(de)
|
1998-04-24 |
2003-12-11 |
K U Leuven Res & Dev Leuven |
Immununterdrückende Effekte von 8 substituierten Xanthinderivaten
|
TR200003353T2
(tr)
|
1998-05-15 |
2001-04-20 |
Astrazeneca Ab |
Sitokinlerin aracılık ettiği hastalıkların tedavisi için benzamit türevleri
|
US6197599B1
(en)
|
1998-07-30 |
2001-03-06 |
Guorong Chin |
Method to detect proteins
|
KR20010072080A
(ko)
|
1998-07-31 |
2001-07-31 |
쓰끼하시 다미까따 |
페닐아졸 화합물, 그의 제조 방법 및 고지혈증용 약제
|
TR200100840T2
(tr)
|
1998-09-25 |
2001-10-22 |
Astrazeneca Ab |
Benzamid türevleri ve bunların sitokin inhibe edicileri olarak kullanımı
|
AU6111699A
(en)
|
1998-10-08 |
2000-05-01 |
Smithkline Beecham Plc |
Novel method and compounds
|
GB9823873D0
(en)
|
1998-10-30 |
1998-12-30 |
Pharmacia & Upjohn Spa |
2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
|
EP1140840B1
(en)
|
1999-01-13 |
2006-03-22 |
Bayer Pharmaceuticals Corp. |
-g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
WO2000041698A1
(en)
|
1999-01-13 |
2000-07-20 |
Bayer Corporation |
φ-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
|
US7928239B2
(en)
|
1999-01-13 |
2011-04-19 |
Bayer Healthcare Llc |
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
UA73492C2
(en)
|
1999-01-19 |
2005-08-15 |
|
Aromatic heterocyclic compounds as antiinflammatory agents
|
NZ528846A
(en)
|
1999-03-12 |
2005-05-27 |
Boehringer Ingelheim Pharma |
Compounds useful as anti-inflammatory agents
|
JP2000275886A
(ja)
|
1999-03-23 |
2000-10-06 |
Konica Corp |
電子写真感光体、それを用いたプロセスカートリッジ及び画像形成装置
|
US6548529B1
(en)
|
1999-04-05 |
2003-04-15 |
Bristol-Myers Squibb Company |
Heterocyclic containing biphenyl aP2 inhibitors and method
|
US6410254B1
(en)
|
1999-05-18 |
2002-06-25 |
Cytokinetics |
Compositions and assays utilizing ADP or phosphate for detecting protein modulators
|
WO2000071515A2
(en)
|
1999-05-24 |
2000-11-30 |
Cor Therapeutics, Inc |
INHIBITORS OF FACTOR Xa
|
JP3972163B2
(ja)
|
1999-06-18 |
2007-09-05 |
株式会社大塚製薬工場 |
ホスホン酸ジエステル誘導体
|
CZ2002534A3
(cs)
|
1999-08-13 |
2002-07-17 |
Vertex Pharmaceuticals Incorporated |
Inhibitory protein-kináz, farmaceutické prostředky, které je obsahují, a jejich pouľití
|
AR035016A1
(es)
|
1999-08-25 |
2004-04-14 |
Takeda Chemical Industries Ltd |
Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
|
US7071199B1
(en)
|
1999-09-17 |
2006-07-04 |
Abbott Gmbh & Cco. Kg |
Kinase inhibitors as therapeutic agents
|
US6525046B1
(en)
|
2000-01-18 |
2003-02-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as antiinflammatory agents
|
US6906063B2
(en)
|
2000-02-04 |
2005-06-14 |
Portola Pharmaceuticals, Inc. |
Platelet ADP receptor inhibitors
|
GB0008264D0
(en)
|
2000-04-04 |
2000-05-24 |
Smithkline Beecham Plc |
Novel method and compounds
|
US6500628B1
(en)
|
2000-05-25 |
2002-12-31 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules encoding human kinase and phosphatase homologues and uses therefor
|
WO2001096298A2
(en)
|
2000-06-14 |
2001-12-20 |
Warner-Lambert Company |
1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
|
JP2004501913A
(ja)
|
2000-06-23 |
2004-01-22 |
ブリストル−マイヤーズ スクイブ ファーマ カンパニー |
ヘテロアリール−フェニル置換Xa因子阻害剤
|
EP1310494B1
(en)
|
2000-08-11 |
2012-01-25 |
Nippon Chemiphar Co., Ltd. |
PPAR (delta) ACTIVATORS
|
US6645990B2
(en)
|
2000-08-15 |
2003-11-11 |
Amgen Inc. |
Thiazolyl urea compounds and methods of uses
|
US20020173507A1
(en)
|
2000-08-15 |
2002-11-21 |
Vincent Santora |
Urea compounds and methods of uses
|
AU2002214626A1
(en)
|
2000-09-29 |
2002-04-08 |
Cor Therapeutics, Inc. |
Quaternary amines and related inhibitors of factor xa
|
US20040058903A1
(en)
|
2000-10-05 |
2004-03-25 |
Hisashi Takasugi |
Benzamide compounds as apo b secretion inhibitors
|
EP1337255A4
(en)
|
2000-10-19 |
2006-01-25 |
Smithkline Beecham Corp |
USE OF P38 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY COUGH
|
AU1826202A
(en)
|
2000-10-27 |
2002-05-06 |
Novartis Ag |
Treatment of gastrointestinal stromal tumors
|
US7235576B1
(en)
|
2001-01-12 |
2007-06-26 |
Bayer Pharmaceuticals Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
JP2002226464A
(ja)
|
2001-01-30 |
2002-08-14 |
Sumitomo Pharmaceut Co Ltd |
トリアリール類縁体およびその利用
|
WO2002066442A1
(en)
|
2001-02-15 |
2002-08-29 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
|
CA2439263C
(en)
|
2001-03-02 |
2012-10-23 |
Frank Becker |
Three hybrid assay system
|
AU2002316459A1
(en)
|
2001-07-11 |
2003-01-29 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Methods of treating cytokine mediated diseases
|
EP1281399A3
(en)
|
2001-08-01 |
2004-02-11 |
Warner-Lambert Company |
Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
|
EP1427412A1
(en)
|
2001-09-13 |
2004-06-16 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Methods of treating cytokine mediated diseases
|
PT1450799E
(pt)
|
2001-12-03 |
2007-01-31 |
Bayer Pharmaceuticals Corp |
Compostos de arilureia em combinação com outros agentes citostáticos ou citotóxicos para tratamento de cancros humanos
|
US7094801B2
(en)
|
2001-12-19 |
2006-08-22 |
Atherogenics, Inc. |
Chalcone derivatives and their use to treat diseases
|
WO2003059373A2
(en)
|
2002-01-16 |
2003-07-24 |
Ramot At Tel Aviv University Ltd. |
Compositions and their use for enhancing and inhibiting fertilization
|
WO2003063822A2
(en)
|
2002-02-01 |
2003-08-07 |
Pfizer Products Inc. |
Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
|
RU2288703C2
(ru)
|
2002-02-01 |
2006-12-10 |
Пфайзер Продактс Инк. |
Способ создания однородных высушенных распылением твердых аморфных лекарственных дисперсных систем с использованием распыляющих напорных форсунок (варианты) и продукт
|
US20030216396A1
(en)
|
2002-02-11 |
2003-11-20 |
Bayer Corporation |
Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
|
US20040023961A1
(en)
|
2002-02-11 |
2004-02-05 |
Bayer Corporation |
Aryl ureas with raf kinase and angiogenisis inhibiting activity
|
EP2324825A1
(en)
|
2002-02-11 |
2011-05-25 |
Bayer Healthcare LLC |
Aryl ureas with angiogenesis inhibiting activity
|
EP1480973B1
(en)
|
2002-02-25 |
2008-02-13 |
Boehringer Ingelheim Pharmaceuticals Inc. |
1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
|
MXPA04008379A
(es)
|
2002-02-28 |
2004-11-26 |
Hoffmann La Roche |
Derivados de tiazol como antagonistas del receptor de neuropeptido y (npy).
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
US20030225089A1
(en)
|
2002-04-10 |
2003-12-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
|
AU2003246927A1
(en)
|
2002-07-03 |
2004-01-23 |
Astex Technology Limited |
3-`(hetero) arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
|
US20040138216A1
(en)
|
2002-12-23 |
2004-07-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Process for the preparation of an essentially pure polymorph of an n-pyrazolyl-n'-naphthyl-urea
|
US20040171075A1
(en)
|
2002-12-31 |
2004-09-02 |
Flynn Daniel L |
Modulation of protein functionalities
|
US7279576B2
(en)
|
2002-12-31 |
2007-10-09 |
Deciphera Pharmaceuticals, Llc |
Anti-cancer medicaments
|
US20080045531A1
(en)
|
2002-12-31 |
2008-02-21 |
Flynn Daniel L |
Anti-inflammatory medicaments
|
US7144911B2
(en)
|
2002-12-31 |
2006-12-05 |
Deciphera Pharmaceuticals Llc |
Anti-inflammatory medicaments
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
WO2005024755A2
(en)
|
2002-12-31 |
2005-03-17 |
Deciphera Pharmaceuticals, Llc. |
Medicaments for the treatment of neurodegenerative disorders or diabetes
|
DE602004030222D1
(de)
|
2003-02-28 |
2011-01-05 |
Bayer Healthcare Llc |
2-oxo-1,3,5-perhydrotriazapinderivate, die sich zur behandlung von hyperproliferativen, angiogenen und entzündlichen erkrankungen eignen
|
UY28213A1
(es)
|
2003-02-28 |
2004-09-30 |
Bayer Pharmaceuticals Corp |
Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
|
WO2004078128A2
(en)
|
2003-02-28 |
2004-09-16 |
Bayer Pharmaceuticals Corporation |
Substituted pyridine derivatives useful in the treatment of cancer and other disorders
|
US20050014753A1
(en)
|
2003-04-04 |
2005-01-20 |
Irm Llc |
Novel compounds and compositions as protein kinase inhibitors
|
WO2004113352A1
(en)
|
2003-06-19 |
2004-12-29 |
Amedis Pharmaceuticals Ltd. |
Silylated heterocyclylurea derivatives as cytokine-inhibitors
|
WO2005002673A1
(en)
|
2003-07-03 |
2005-01-13 |
Astex Therapeutics Limited |
Raf kinase inhibitors
|
RS20060035A
(en)
|
2003-07-22 |
2008-08-07 |
Arena Pharmaceuticals Inc., |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
|
CL2004001884A1
(es)
|
2003-08-04 |
2005-06-03 |
Pfizer Prod Inc |
Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
|
CN1863774B
(zh)
|
2003-10-08 |
2010-12-15 |
Irm责任有限公司 |
用作蛋白激酶抑制剂的化合物和组合物
|
US20050171172A1
(en)
|
2003-11-13 |
2005-08-04 |
Ambit Biosciences Corporation |
Amide derivatives as PDGFR modulators
|
US20080220497A1
(en)
|
2003-12-24 |
2008-09-11 |
Flynn Daniel L |
Modulation of protein functionalities
|
US20070191336A1
(en)
|
2003-12-24 |
2007-08-16 |
Flynn Daniel L |
Anti-inflammatory medicaments
|
ATE548353T1
(de)
|
2004-03-23 |
2012-03-15 |
Arena Pharm Inc |
Verfahren zur herstellung von substituierte n- aryl-n'-ä3-(1h-pyrazol-5-yl)phenylü-harnstoffe and intermediate davon.
|
EP1751139B1
(en)
|
2004-04-30 |
2011-07-27 |
Bayer HealthCare LLC |
Substituted pyrazolyl urea derivatives useful in the treatment of cancer
|
US7977345B2
(en)
|
2004-07-02 |
2011-07-12 |
Exelixis, Inc. |
c-MET modulators and method of use
|
US20080261952A1
(en)
|
2004-08-16 |
2008-10-23 |
Jason Bloxham |
Aryl Urea Derivatives for Treating Obesity
|
MX2007002584A
(es)
|
2004-09-02 |
2007-09-07 |
Genentech Inc |
Inhibidores de piridilo de senalizacion de hedgehog.
|
US20070054916A1
(en)
|
2004-10-01 |
2007-03-08 |
Amgen Inc. |
Aryl nitrogen-containing bicyclic compounds and methods of use
|
MX2007004248A
(es)
|
2004-10-13 |
2007-06-12 |
Merck Patent Gmbh |
Derivados heterociclicos de bisarilurea sustituidos como inhibidores de cinasa.
|
JP5314244B2
(ja)
|
2004-10-27 |
2013-10-16 |
富山化学工業株式会社 |
新規な含窒素複素環化合物およびその塩
|
GT200500321A
(es)
|
2004-11-09 |
2006-09-04 |
|
Compuestos y composiciones como inhibidores de proteina kinase.
|
EP1824843A2
(en)
|
2004-12-07 |
2007-08-29 |
Locus Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
AU2005325676A1
(en)
|
2004-12-23 |
2006-08-03 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
EP1835934A4
(en)
|
2004-12-23 |
2010-07-28 |
Deciphera Pharmaceuticals Llc |
ENZYME MODULATORS AND TREATMENTS
|
GB0500435D0
(en)
|
2005-01-10 |
2005-02-16 |
Novartis Ag |
Organic compounds
|
US7622583B2
(en)
|
2005-01-14 |
2009-11-24 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
JP2008527042A
(ja)
|
2005-01-19 |
2008-07-24 |
アリーナ ファーマシューティカルズ, インコーポレイテッド |
進行性多病巣性白質脳障害の予防または治療に有用な、5−ht2aセロトニン受容体の調節因子としてのジアリールおよびアリールヘテロアリール尿素誘導体
|
AR052886A1
(es)
|
2005-01-26 |
2007-04-11 |
Arena Pharm Inc |
Procedimientos para preparar fenilpirazol ureas sustituidas y para la obtencion de sus intermediarios de sintesis
|
US9265731B2
(en)
|
2005-01-28 |
2016-02-23 |
Bend Research, Inc. |
Drying of drug-containing particles
|
ES2543607T3
(es)
|
2005-03-10 |
2015-08-20 |
Gilead Connecticut, Inc. |
Ciertas amidas sustituidas, método de obtención, y método de su uso
|
DE102005015253A1
(de)
|
2005-04-04 |
2006-10-05 |
Merck Patent Gmbh |
Pyrazolderivate
|
EP1934181A2
(en)
|
2005-10-13 |
2008-06-25 |
Devgen NV |
Kinase inhibitors
|
US20110195110A1
(en)
|
2005-12-01 |
2011-08-11 |
Roger Smith |
Urea compounds useful in the treatment of cancer
|
TW200804349A
(en)
|
2005-12-23 |
2008-01-16 |
Kalypsys Inc |
Novel substituted pyrimidinyloxy ureas as inhibitors of protein kinases
|
WO2007081690A2
(en)
|
2006-01-04 |
2007-07-19 |
Locus Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
AU2007236321A1
(en)
|
2006-04-12 |
2007-10-18 |
Merck Patent Gmbh |
N-oxides of heterocyclic substituted bisarylureas for treating kinase-mediated diseases
|
WO2007125330A1
(en)
|
2006-04-26 |
2007-11-08 |
Cancer Research Technology Limited |
Imidazo[4, 5-b]pyridin-2-one and oxazolo[4, 5-b]pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds
|
US20090312321A1
(en)
|
2006-05-15 |
2009-12-17 |
Irm Llc |
Compositions and methods for fgf receptor kinases inhibitors
|
US20080064717A1
(en)
|
2006-05-19 |
2008-03-13 |
Rajesh Iyengar |
Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
|
JP2010502751A
(ja)
|
2006-09-11 |
2010-01-28 |
シージーアイ ファーマシューティカルズ,インコーポレイティド |
キナーゼ阻害物質、およびキナーゼ阻害物質の使用および同定方法
|
CN101516379A
(zh)
|
2006-09-14 |
2009-08-26 |
迪赛孚尔制药有限公司 |
可用于治疗增殖性疾病的激酶抑制剂
|
US8188113B2
(en)
|
2006-09-14 |
2012-05-29 |
Deciphera Pharmaceuticals, Inc. |
Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
US7897762B2
(en)
|
2006-09-14 |
2011-03-01 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of proliferative diseases
|
US7790756B2
(en)
|
2006-10-11 |
2010-09-07 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
|
US20120225057A1
(en)
|
2006-10-11 |
2012-09-06 |
Deciphera Pharmaceuticals, Llc |
Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases
|
MX2009004141A
(es)
|
2006-10-20 |
2009-05-01 |
Irm Llc |
Composiciones y metodos para modular receptores de c-kit y pdgfr.
|
US20080248487A1
(en)
|
2007-04-09 |
2008-10-09 |
Flynn Daniel L |
Modulation of protein functionalities
|
US20080248548A1
(en)
|
2007-04-09 |
2008-10-09 |
Flynn Daniel L |
Modulation of protein functionalities
|
MY150697A
(en)
|
2007-04-10 |
2014-02-28 |
Exelixis Inc |
Methods of treating cancer using pyridopyrimdinone inhibitors of p13k alpha
|
EP2146717A4
(en)
|
2007-04-20 |
2010-08-11 |
Deciphera Pharmaceuticals Llc |
KINASE INHIBITORS USEFUL FOR THE TREATMENT OF MYOLEOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES
|
US20110189167A1
(en)
|
2007-04-20 |
2011-08-04 |
Flynn Daniel L |
Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative Diseases
|
AU2008294535A1
(en)
|
2007-09-04 |
2009-03-12 |
Biolipox Ab |
BIS-aromatic compounds useful in the treatment of inflammation
|
WO2009076454A2
(en)
|
2007-12-12 |
2009-06-18 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
JP5230755B2
(ja)
|
2008-02-22 |
2013-07-10 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
c−kitおよびPDGFRキナーゼ阻害剤としてのヘテロ環化合物および組成物
|
RU2533827C2
(ru)
|
2008-03-05 |
2014-11-20 |
Метилджин Инк. |
Ингибиторы активности протеинтирозинкиназы
|
US20090281089A1
(en)
|
2008-04-11 |
2009-11-12 |
Genentech, Inc. |
Pyridyl inhibitors of hedgehog signalling
|
CA2721452A1
(en)
|
2008-04-16 |
2009-10-22 |
Biolipox Ab |
Bis-aryl compounds for use as medicaments
|
US20110112193A1
(en)
|
2008-05-14 |
2011-05-12 |
Peter Nilsson |
Bis-aryl compounds for use as medicaments
|
EP2323665B1
(en)
|
2008-07-24 |
2013-06-19 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
JP5444365B2
(ja)
|
2008-10-29 |
2014-03-19 |
デシフェラ ファーマシューティカルズ,エルエルシー |
抗癌活性および抗増殖活性を示すシクロプロパンアミドおよび類似物質
|
ES2873502T3
(es)
|
2009-03-27 |
2021-11-03 |
Bend Res Inc |
Proceso de secado por pulverización
|
WO2010124283A2
(en)
|
2009-04-24 |
2010-10-28 |
The Jackson Laboratory |
Methods and compositions relating to hematologic malignancies
|
CN102459249A
(zh)
|
2009-05-22 |
2012-05-16 |
埃克塞里艾克西斯公司 |
作为PI3K/mTOR抑制剂的苯并氧氮杂环庚三烯以及它们使用与制造方法
|
US8394858B2
(en)
|
2009-12-03 |
2013-03-12 |
Novartis Ag |
Cyclohexane derivatives and uses thereof
|
US20110237563A1
(en)
|
2010-03-23 |
2011-09-29 |
Dominique Costantini |
Fast dissolving drug delivery systems
|
WO2011123788A1
(en)
|
2010-04-01 |
2011-10-06 |
Duke University |
Compositions and methods for the treatment of cancer
|
WO2011139891A1
(en)
|
2010-04-29 |
2011-11-10 |
Deciphera Pharmaceuticals, Llc |
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activites
|
ES2475741T3
(es)
|
2010-04-29 |
2014-07-11 |
Deciphera Pharmaceuticals, Llc |
Ciclopropil dicarboxamidas y análogos que presentan actividades antic�ncer y antiproliferativas
|
US9296722B2
(en)
|
2010-05-27 |
2016-03-29 |
Ambit Biosciences Corporation |
Azolyl urea compounds and methods of use thereof
|
US20130225581A1
(en)
|
2010-07-16 |
2013-08-29 |
Kyowa Hakko Kirin Co., Ltd |
Nitrogen-containing aromatic heterocyclic derivative
|
WO2012035131A1
(en)
|
2010-09-16 |
2012-03-22 |
University Of Zurich |
Treatment of abl overexpressing b-cell lymphoma
|
US9248584B2
(en)
|
2010-09-24 |
2016-02-02 |
Bend Research, Inc. |
High-temperature spray drying process and apparatus
|
US20140147415A1
(en)
|
2010-11-05 |
2014-05-29 |
Ab Science |
Treatment of mastocytosis with masitinib
|
BR112013012953A2
(pt)
|
2010-11-24 |
2019-09-24 |
Exelixis Inc |
benzoxazepinas asn inhibidoras de p13k/m tor e métodos de seu uso e fabricação
|
ES2689760T3
(es)
|
2011-01-11 |
2018-11-15 |
Novartis Ag |
Combinación de bortezomib con afuresertib y uso de la misma en el tratamiento de cáncer
|
US20140296248A1
(en)
|
2011-04-04 |
2014-10-02 |
Stichting het Nederlands Kanker Instiuut-Antoni van Leeuwenhoek ziekenhuis |
Methods and compositions for predicting resistance to anticancer treatment
|
CN102731385A
(zh)
|
2011-04-08 |
2012-10-17 |
湖南有色凯铂生物药业有限公司 |
3-氯-及3-甲氧基-n-甲基-2-吡啶酰胺化合物及其作为抗癌药物的应用
|
JP6158180B2
(ja)
|
2011-07-29 |
2017-07-05 |
メディベイション プロステイト セラピューティクス, インコーポレイテッド |
乳がんの処置
|
WO2013036232A2
(en)
|
2011-09-08 |
2013-03-14 |
Deciphera Pharmaceuticals, Llc |
Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases
|
US20130071403A1
(en)
|
2011-09-20 |
2013-03-21 |
Vical Incorporated |
Synergistic anti-tumor efficacy using alloantigen combination immunotherapy
|
CA3114454C
(en)
*
|
2011-10-14 |
2022-11-29 |
Array Biopharma Inc. |
A solid dispersion of n4-(4-([1,2,4]triazolo[1,5-.alpha.]pyridin-7-yloxy)-3-methylphenyl)-n6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine
|
CN104302292A
(zh)
|
2011-11-22 |
2015-01-21 |
德西费拉制药有限责任公司 |
表现出抗癌和抗增殖活性的吡啶酮酰胺以及类似物
|
KR101338510B1
(ko)
|
2011-12-09 |
2013-12-11 |
포항공과대학교 산학협력단 |
아미노퀴놀론 화합물을 포함하는 간염, 간경변, 또는 간암의 예방 또는 치료용 의약 조성물
|
WO2013134298A1
(en)
|
2012-03-07 |
2013-09-12 |
Deciphera Pharmaceuticals, Llc |
Raf inhibitor compounds
|
AR090151A1
(es)
|
2012-03-07 |
2014-10-22 |
Lilly Co Eli |
Compuestos inhibidores de raf
|
NZ756264A
(en)
*
|
2012-03-23 |
2022-09-30 |
Array Biopharma Inc |
Treatment of brain cancer
|
US9254288B2
(en)
|
2012-05-07 |
2016-02-09 |
The Translational Genomics Research Institute |
Susceptibility of tumors to tyrosine kinase inhibitors and treatment thereof
|
US9801851B2
(en)
|
2012-05-23 |
2017-10-31 |
St. Jude Children's Research Hospital |
Methods and compositions for the treatment of BCR-ABL positive lymphoblastic leukemias
|
EP3722296A3
(en)
|
2012-06-07 |
2020-10-21 |
Deciphera Pharmaceuticals, LLC |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
US8461179B1
(en)
|
2012-06-07 |
2013-06-11 |
Deciphera Pharmaceuticals, Llc |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
WO2014015056A2
(en)
|
2012-07-17 |
2014-01-23 |
Washington University |
Anti-mucus drugs and uses therefor
|
EP2890380A2
(en)
|
2012-08-29 |
2015-07-08 |
Merck Patent GmbH |
Ddr2 inhibitors for the treatment of osteoarthritis
|
JP6223451B2
(ja)
|
2012-08-31 |
2017-11-01 |
ザ リージェンツ オブ ザ ユニヴァーシティ オブ コロラド,ア ボディ コーポレイト |
がんの診断及び治療方法
|
EP2892893B2
(en)
|
2012-09-10 |
2019-10-16 |
F.Hoffmann-La Roche Ag |
6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
WO2014040242A1
(zh)
|
2012-09-12 |
2014-03-20 |
湖南有色凯铂生物药业有限公司 |
3-氯-及3-甲氧基-n-甲基-2-吡啶酰胺化合物及其作为抗癌药物的应用
|
CN103664787B
(zh)
|
2012-09-17 |
2015-09-09 |
南京圣和药业股份有限公司 |
炔杂芳环化合物及其应用
|
US20150275306A1
(en)
|
2012-10-10 |
2015-10-01 |
Stichting Het Nederlands Kanker Instituut Antoni van Leeuwenhoek Ziekenhuis |
Methods and means for predicting resistance to anti-cancer treatment
|
FR3000492B1
(fr)
|
2012-12-28 |
2015-09-11 |
Oribase Pharma |
Nouveaux derives azaindole en tant qu'inhibiteurs multikinases
|
FR3000493A1
(fr)
|
2012-12-28 |
2014-07-04 |
Oribase Pharma |
Nouveaux inhibiteurs de proteines kinases
|
WO2014160183A1
(en)
|
2013-03-13 |
2014-10-02 |
The United States Of America,As Represented By The Secretary,Department Of Health And Human Services |
Methods for modulating chemotherapeutic cytotoxicity
|
CN104045642B
(zh)
|
2013-03-14 |
2016-08-24 |
上海医药工业研究院 |
含嘧啶或吡啶的稠环化合物及其作为抗肿瘤药物的应用
|
CN105228620B
(zh)
|
2013-03-15 |
2020-09-04 |
德西费拉制药有限责任公司 |
展现抗癌和抗增殖活性的n-酰基-n′-(吡啶-2-基)脲及类似物
|
US9133183B2
(en)
|
2013-03-15 |
2015-09-15 |
Deciphera Pharmaceuticals, Llc |
Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities
|
US9012635B2
(en)
|
2013-03-15 |
2015-04-21 |
Deciphera Pharmaceuticals, Llc |
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
|
WO2014145023A1
(en)
|
2013-03-15 |
2014-09-18 |
Deciphera Pharmaceuticals, Llc |
1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities
|
KR102628583B1
(ko)
|
2013-03-15 |
2024-01-25 |
데시페라 파마슈티칼스, 엘엘씨. |
항암 및 항-증식 활성을 나타내는 2-아미노피리미딘-6-온 및 유사체
|
US9309224B2
(en)
|
2013-03-15 |
2016-04-12 |
Deciphera Pharmaceuticals, Llc. |
N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
|
US20160101106A1
(en)
|
2013-05-07 |
2016-04-14 |
Inhibikase Therapeutics, Inc. |
Methods for treating hcv infection
|
FR3008979B1
(fr)
|
2013-07-23 |
2015-07-24 |
Servier Lab |
Nouveaux derives phosphates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
US10111897B2
(en)
|
2013-10-03 |
2018-10-30 |
Duke University |
Compositions and methods for treating cancer with JAK2 activity
|
WO2015069217A1
(en)
|
2013-11-05 |
2015-05-14 |
Baylor College Of Medicine |
Src kinase inhibition as treatment for lympangioleiomyomatosis and tuberous sclerosis
|
KR20160070188A
(ko)
|
2013-11-07 |
2016-06-17 |
데시페라 파마슈티칼스, 엘엘씨. |
암치료에 유용한 tie2 키나아제의 억제 방법
|
US9457019B2
(en)
|
2013-11-07 |
2016-10-04 |
Deciphera Pharmaceuticals, Llc |
Methods for inhibiting tie-2 kinase useful in the treatment of cancer
|
EP3072964A1
(en)
|
2013-11-22 |
2016-09-28 |
National Center For Child Health And Development |
Novel chimera gene atf7ip-pdgfrb for acute lymphoblastic leukemia
|
JP6514703B2
(ja)
|
2013-12-20 |
2019-05-15 |
トピバート ファーマ リミテッド |
キナーゼインヒビターとして有用な尿素誘導体
|
WO2015106292A1
(en)
|
2014-01-13 |
2015-07-16 |
Coferon, Inc. |
Bcr-abl tyrosine-kinase ligands capable of dimerizing in an aqueous solution, and methods of using same
|
WO2015106294A1
(en)
|
2014-01-13 |
2015-07-16 |
Coferon,Inc. |
Bivalent bcr-abl tyrosine kinase ligands, and methods of using same
|
CA2944043A1
(en)
|
2014-03-25 |
2015-10-01 |
University Of Utah Research Foundation |
Peptide inhibitors of bcr-abl oligomerization
|
WO2015184443A1
(en)
|
2014-05-30 |
2015-12-03 |
The Regents Of The University Of Colorado |
Activating ntrk1 gene fusions predictive of kinase inhibitor therapy
|
JP2017523206A
(ja)
*
|
2014-08-07 |
2017-08-17 |
ファーマサイクリックス エルエルシー |
ブルトン型チロシンキナーゼ阻害剤の新規製剤
|
CN105461699B
(zh)
|
2014-09-25 |
2019-07-09 |
广东东阳光药业有限公司 |
取代的杂环化合物及其使用方法和用途
|
WO2016061231A1
(en)
|
2014-10-14 |
2016-04-21 |
Deciphera Pharmaceuticals, Llc |
Inhibition of tumor cell interactions with the microenvironment resulting in a reduction in tumor growth and disease progression
|
JP2017532344A
(ja)
|
2014-10-14 |
2017-11-02 |
デシファラ ファーマスーティカルズ, エルエルシー |
Trkキナーゼ媒介性の腫瘍の増殖および疾患進行の阻害
|
WO2016090240A1
(en)
|
2014-12-04 |
2016-06-09 |
Astex Pharmaceuticals, Inc. |
Pharmaceutical compositions for increasing the bioavailability of poorly soluble drugs
|
US20160166679A1
(en)
|
2014-12-12 |
2016-06-16 |
Purdue Research Foundation |
Method of treatment using folate conjugates and tyrosine kinase inhibitors
|
EP3034092A1
(en)
|
2014-12-17 |
2016-06-22 |
Université de Lausanne |
Adoptive immunotherapy for treating cancer
|
WO2016103223A1
(en)
|
2014-12-23 |
2016-06-30 |
Fratagene Therapeutics Ltd. |
Methods of treating friedreich's ataxia using src inhibitors
|
EP3789027A1
(en)
|
2015-01-13 |
2021-03-10 |
Kyoto University |
Bosutinib, sunitinib, tivozanib, imatinib, nilotinib, rebastinib or bafetinib for preventing and/or treating amyotrophic lateral sclerosis
|
US9637488B2
(en)
|
2015-01-29 |
2017-05-02 |
Fuqiang Ruan |
Heterocyclic compounds as inhibitors of class I PI3KS
|
WO2016135046A1
(en)
|
2015-02-24 |
2016-09-01 |
Academisch Medisch Centrum |
Inhibitors of raf1, mst1, and pkl1 for use in the treatment of a retrovirus
|
WO2016154524A1
(en)
|
2015-03-26 |
2016-09-29 |
Emory University |
Carbonic anhydrase inhibitors and uses related thereto
|
AU2016270321B2
(en)
|
2015-05-29 |
2020-09-10 |
Ignyta, Inc. |
Compositions and methods for treating patients with RTK mutant cells
|
EP3120851A1
(en)
|
2015-07-21 |
2017-01-25 |
Pangaea Biotech S.L. |
4-amino-6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)-pyrido[2,3-d]pyrimidin-7(8h)-one for treatment of solid cancers
|
WO2017042944A1
(ja)
|
2015-09-10 |
2017-03-16 |
国立大学法人山梨大学 |
フィラデルフィア染色体陽性(Ph+)急性リンパ性白血病(ALL)の治療薬又は治療方法
|
MX2018005340A
(es)
|
2015-11-02 |
2018-05-17 |
Univ Yale |
Proteolisis de direccionamiento a compuestos de quimera y metodos de preparacion y uso de los mismos.
|
WO2017117182A1
(en)
|
2015-12-29 |
2017-07-06 |
Board Of Regents, The University Of Texas System |
Inhibition of p38 mapk for the treatment of cancer
|
CN109069410B
(zh)
|
2016-02-26 |
2022-05-31 |
安吉奥斯医药品有限公司 |
用于治疗血液恶性肿瘤和实体瘤的idh1抑制剂
|
WO2017214514A1
(en)
|
2016-06-09 |
2017-12-14 |
Bioxcel Corporation |
Use of src family kinase inhibitor in ribosomal disorder
|
WO2018005737A1
(en)
|
2016-06-29 |
2018-01-04 |
The General Hospital Corporation |
Renal clearable organic nanocarriers
|
TWI752083B
(zh)
|
2016-09-13 |
2022-01-11 |
日商協和麒麟股份有限公司 |
醫藥組合物
|
EP3512519A1
(en)
|
2016-09-14 |
2019-07-24 |
Gilead Sciences, Inc. |
Syk inhibitors
|
TW201822764A
(zh)
|
2016-09-14 |
2018-07-01 |
美商基利科學股份有限公司 |
Syk抑制劑
|
WO2018106595A1
(en)
|
2016-12-05 |
2018-06-14 |
Fate Therapeutics, Inc. |
Compositions and methods for immune cell modulation in adoptive immunotherapies
|
CN106822128A
(zh)
|
2017-02-24 |
2017-06-13 |
南华大学附属第医院 |
酪氨酸激酶抑制剂dcc‑2036的新应用
|
AU2018254577A1
(en)
|
2017-04-21 |
2019-12-05 |
Epizyme, Inc. |
Combination therapies with EHMT2 inhibitors
|
WO2018222644A1
(en)
|
2017-05-30 |
2018-12-06 |
Albert Einstein College Of Medicine, Inc. |
Method for treating neoadjuvant chemotherapy-induced metastasis
|
MX2019014343A
(es)
|
2017-05-30 |
2020-08-03 |
Deciphera Pharmaceuticals Inc |
Uso de 1-[4-bromo-5-[1-etil-7-(metilamino)-2-oxo-1,2-dihidro-1,6-n aftiridin-3-il]-2-fluorofenil]-3-fenilurea y analogos para el tratamiento de canceres asociados con anomalias geneticas en el receptor alfa del factor de crecimiento derivado de plaquetas.
|
TWI803530B
(zh)
*
|
2017-10-27 |
2023-06-01 |
美商普雷辛肯公司 |
調節激酶之化合物之調配物
|
CN111886006A
(zh)
|
2018-01-31 |
2020-11-03 |
德西费拉制药有限责任公司 |
治疗肥大细胞增多症的组合疗法
|
CN115192726A
(zh)
|
2018-04-03 |
2022-10-18 |
深圳大学 |
免疫激动剂靶向化合物的合成及其应用
|
BR112021012812A2
(pt)
|
2018-12-28 |
2021-12-07 |
Deciphera Pharmaceuticals Llc |
Csf1r inhibitors para uso e tratamento de câncer
|
WO2020185812A1
(en)
*
|
2019-03-11 |
2020-09-17 |
Teva Pharmaceuticals International Gmbh |
Solid state forms of ripretinib
|
RS65019B1
(sr)
|
2019-05-10 |
2024-01-31 |
Deciphera Pharmaceuticals Llc |
Fenilaminopirimidin amidni inhibitori autofagije i postupci njihove primene
|
MX2021013662A
(es)
|
2019-05-10 |
2022-03-11 |
Deciphera Pharmaceuticals Llc |
Inhibidores de la autofagia de heteroarilaminopirimidina amida y metodos de uso de estos.
|
JP2022544234A
(ja)
|
2019-08-12 |
2022-10-17 |
デシフェラ・ファーマシューティカルズ,エルエルシー |
胃腸間質腫瘍を治療するためのリプレチニブ
|
TW202122082A
(zh)
|
2019-08-12 |
2021-06-16 |
美商迪賽孚爾製藥有限公司 |
治療胃腸道基質瘤方法
|
IL293866A
(en)
|
2019-12-30 |
2022-08-01 |
Deciphera Pharmaceuticals Llc |
Compositions of amorphous kinase inhibitors and methods of using them
|
IL293864A
(en)
|
2019-12-30 |
2022-08-01 |
Deciphera Pharmaceuticals Llc |
Preparations of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3- phenylurea
|
CN114902895B
(zh)
|
2022-04-06 |
2023-12-12 |
安徽科技学院 |
一种基于蔬菜种植的能源回收式大棚
|